Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 6,300.00
-330.00 (-4.98%)
At close: May 29, 2026
Pharos iBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | - | - | - | - | 300 | 57 |
Other Revenue | - | - | - | - | - | -0 |
| - | - | - | - | 300 | 57 | |
Revenue Growth (YoY) | - | - | - | - | 426.32% | -69.63% |
Cost of Revenue | 19.42 | 20.32 | 25.93 | 11.02 | 192.49 | 52.09 |
Gross Profit | -19.42 | -20.32 | -25.93 | -11.02 | 107.52 | 4.91 |
Selling, General & Admin | 3,055 | 2,913 | 3,276 | 3,226 | 2,988 | 2,459 |
Research & Development | 6,768 | 7,677 | 8,458 | 6,138 | 7,085 | 5,544 |
Amortization of Goodwill & Intangibles | 57.35 | 73.12 | 71.31 | 69.18 | 67.33 | 111.15 |
Other Operating Expenses | 59.68 | 59.25 | 38.31 | 56.29 | 75.93 | 57.34 |
Operating Expenses | 10,707 | 11,487 | 12,575 | 10,106 | 10,727 | 8,411 |
Operating Income | -10,726 | -11,507 | -12,601 | -10,117 | -10,619 | -8,406 |
Interest Expense | -485.52 | -63.57 | -6.01 | -11.24 | -3,222 | -6,513 |
Interest & Investment Income | 377.62 | 341.88 | 809.98 | 690.24 | 320.48 | 116.43 |
Currency Exchange Gain (Loss) | 213.6 | -110.47 | 717.62 | 28.37 | 346.05 | 205.32 |
Other Non Operating Income (Expenses) | 583.68 | 582.62 | 556.6 | 592.65 | -3,911 | -16,877 |
EBT Excluding Unusual Items | -9,937 | -10,757 | -10,523 | -8,817 | -17,086 | -31,474 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -37.27 | -41.7 | 24.43 | 3.2 |
Pretax Income | -9,937 | -10,757 | -10,560 | -8,858 | -17,062 | -31,471 |
Net Income | -9,937 | -10,757 | -10,560 | -8,858 | -17,062 | -31,471 |
Net Income to Common | -9,937 | -10,757 | -10,560 | -8,858 | -17,062 | -31,471 |
Shares Outstanding (Basic) | 13 | 13 | 13 | 12 | 9 | 6 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 12 | 9 | 6 |
Shares Change (YoY) | 0.04% | 0.16% | 6.81% | 36.26% | 53.03% | 2.65% |
EPS (Basic) | -767.86 | -830.89 | -817.00 | -732.03 | -1921.10 | -5422.59 |
EPS (Diluted) | -767.86 | -830.89 | -817.00 | -732.03 | -1921.10 | -5422.59 |
Free Cash Flow | -7,980 | -8,362 | -10,004 | -8,253 | -8,512 | -8,489 |
Free Cash Flow Per Share | -616.61 | -645.96 | -773.98 | -681.98 | -958.46 | -1462.70 |
Gross Margin | - | - | - | - | 35.84% | 8.61% |
Operating Margin | - | - | - | - | -3539.83% | -14747.27% |
Profit Margin | - | - | - | - | -5687.23% | -55211.96% |
Free Cash Flow Margin | - | - | - | - | -2837.42% | -14892.94% |
EBITDA | -9,902 | -10,670 | -11,798 | -9,432 | -10,041 | -8,056 |
D&A For EBITDA | 824.07 | 837.49 | 802.91 | 684.91 | 578.1 | 350.09 |
EBIT | -10,726 | -11,507 | -12,601 | -10,117 | -10,619 | -8,406 |
Advertising Expenses | - | 109.8 | 47.12 | - | - | 0.2 |